BlossomHill Therapeutics, Inc. Balance Sheet
BlossomHill Therapeutics, Inc.'s total assets for Q2 2026 were $124.13M, a decrease of -13.44% from the previous quarter. BLSM total liabilities were $42.09M for the fiscal quarter, a -85.76% a decrease from the previous quarter. See a summary of the company’s assets, liabilities, and equity.